Health Care & Life Sciences » Pharmaceuticals | Ilsung Pharmaceutical Co. Ltd.

Ilsung Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Ilsung Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Dimensional Emerging Markets Value Fund
9,407
0.35%
0
0.01%
01/31/2018
DFA Emerging Markets Small Cap Series
3,984
0.15%
0
0.01%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
3,660
0.14%
0
0%
04/30/2018
Lacuna SICAV - Adamant Asia Pacific Health
736
0.03%
736
0.19%
12/31/2017
John Hancock II - Emerging Markets Fund
495
0.02%
0
0%
04/30/2018
Dimensional Funds Plc - Emerging Markets Value Fund
451
0.02%
-599
0%
11/30/2017
425
0.02%
212
0.02%
04/30/2018
John Hancock VIT - Emerging Markets Value Trust
353
0.01%
0
0%
03/31/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
262
0.01%
0
0%
12/31/2017

About Ilsung Pharmaceutical Co.

View Profile
Address
9 Wonhyo-ro 84-gil
Seoul SL 04315
Korea, Republic Of
Employees -
Website http://www.ilsung-ph.co.kr
Updated 07/08/2019
Ilsung Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its products include contrast media, patches, antibiotics, antiviral agents, dermatologic agents, cardiovascular agents, antidiabetic agents, analgesics, muscle relaxants, neuropsychiatric agents, antitussives and expectorants. The company was founded by Yoon Byung-Kang in 1954 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.